Drug Screening Market Insights and Growth by 2031
MARKET OVERVIEW
Drug screening is a technical process, performed for analyzing specimens such as hair, urine, oral fluids, breath and other samples. Drug screening aids in detection of drug or a chemical compound in the body. This process is applied in hospitals, drug testing centers, pain management centers as well as law enforcement agencies. Drug screening tests are also performed by companies and organizations on employees and athletes to check for drug abuse.
MARKET SCOPE
The "Global Drug Screening Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the drug screening market with detailed market segmentation by type, products, Disease Detection, application, and geography. The report provides key statistics on the market status of the leading drug screening market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type, the market is segmented as analytical instruments, rapid testing devices and consumables.
- On the basis of sample, the global drug screening market is segmented into breath, hair, oral fluid, urine and others.
- Based on end user, the market is bifurcated into drug testing laboratories, drug treatment centers, criminal justice systems & law enforcement agencies, pain management centers, hospitals, individuals and others
MARKET DYNAMICS
Drivers
- Increase consumption of alcohol and drugs during the previous years, has been a matter of concern for various employers.
- Various government bodies have been providing funds for drug screening tests.
- Development and adoption of new methods as well as devices for drug screening is anticipated to be the driving factors for the growth of drug screening market.
Restraints
- Bans on alcohol consumption in Islamic countries is likely to restraint the market growth.
- Prohibition of drug testing at workplace
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The drug screening market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the drug screening market in these regions.
IMPACT OF COVID-19 ON DRUG SCREENING MARKET
COVID-19 has ended in significant disruptions to businesses and commercial activities globally. Restrictions and lockdowns were also imposed in travel, business operations, public gatherings, and shelter-in-place orders, all of which have further impacted market growth. However, it is expected to have a short-term negative influence on the drug screening market due to the limited or non-availability of medical departments or treatment centers, harm-reducing service providers, and the fear of infection transmission. In addition, various authorities worldwide provided guidelines to postpone or delay non-essential medical and surgical systems to reduce the strain on the healthcare system and decrease disease transmission.
Drug Screening Market Report Analysis
CAGR (2023 - 2031)
US$ XX Million
US$ XX Million
Report Coverage
Key Players
Regional Overview
Market Segmentation
The report covers key developments in the drug screening market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from drug screening market are anticipated to lucrative growth opportunities in the future with the rising demand for drug screening in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the drug screening market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott
- Omega Laboratories, Inc.
- Roche Monitoring Services.
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Premier Biotech, Inc.
- OraSure Technologies, Inc.
- Psychemedics Corporation
- Laboratory Corporation of America Holdings
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Drug Screening Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Abbott
2. Omega Laboratories, Inc.
3. Roche Monitoring Services.
4. Siemens Healthcare GmbH
5. Thermo Fisher Scientific Inc.
6. Quest Diagnostics Incorporated
7. Premier Biotech, Inc.
8. OraSure Technologies, Inc.
9. Psychemedics Corporation
10. Laboratory Corporation of America Holdings
11. Alere, Inc
12. Drägerwerk AG & Co. KGAA
13. Biorad Laboratories, Inc.
14. Danaher Corporation
15. Express Diagnostics International Inc.